Epigenetic reprogramming induces the expansion of cord blood stem cells
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Cord blood (CB) cells that express CD34 have extensive hematopoietic capacity and rapidly divide ex vivo in the presence of cytokine combinations; however, many of these CB CD34+ cells lose their marrow-repopulating potential. To overcome this decline in function, we treated dividing CB CD34+ cells ex vivo with several histone deacetylase inhibitors (HDACIs). Treatment of CB CD34+ cells with the most active HDACI, valproic acid (VPA), following an initial 16-hour cytokine priming, increased the number of multipotent cells (CD34+CD90+) generated; however, the degree of expansion was substantially greater in the presence of both VPA and cytokines for a full 7 days. Treated CD34+ cells were characterized based on the upregulation of pluripotency genes, increased aldehyde dehydrogenase activity, and enhanced expression of CD90, c-Kit (CD117), integrin α6 (CD49f), and CXCR4 (CD184). Furthermore, siRNA-mediated inhibition of pluripotency gene expression reduced the generation of CD34+CD90+ cells by 89%. Compared with CB CD34+ cells, VPA-treated CD34+ cells produced a greater number of SCID-repopulating cells and established multilineage hematopoiesis in primary and secondary immune-deficient recipient mice. These data indicate that dividing CB CD34+ cells can be epigenetically reprogrammed by treatment with VPA so as to generate greater numbers of functional CB stem cells for use as transplantation grafts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Wilson, A., Laurenti, E., Oser, G., van der Wath, R. C., Blanco-Bose, W., Jaworski, M., Offner, S., Dunant, C. F., Eshkind, L., Bockamp, E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.048 · Cited by 1,908
Isolation of Single Human Hematopoietic Stem Cells Capable of Long-Term Multilineage Engraftment
Notta, F., Doulatov, S., Laurenti, E., Poeppl, A., Jurisica, I., & Dick, J. E. (2011) · Science · doi:10.1126/science.1201219 · Cited by 919 · cited 1×
“…to be able to generate additional CD34 + cells that possessed many features associated with primitive stem cells including increased aldehyde dehydrogenase (ALDH) activity, increased expression of CD90, c-Kit (CD117), integrin α 6 (CD49f), and CXCR4 (CD184), but that lacked CD45RA expression (36).”
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2
Krämer, O. H., Zhu, P., Ostendorff, H. P., Golebiewski, M., Tiefenbach, J., Peters, M. A., Brill, B., Groner, B., Bach, I., Heinzel, T., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg315 · Cited by 523 · cited 2×
“Limiting the amounts of the E2 ubiquitin conjugase Ubc8 and the E3 ubiquitin ligase RLIM has been reported to maintain a balanced steady-state protein level of HDACs that is susceptible to modulation by VPA (37–39).”
Delcuve, G. P., Khan, D. H., & Davie, J. R. (2012) · Clinical Epigenetics · doi:10.1186/1868-7083-4-5 · Cited by 505
Modification of hematopoietic stem cell fate by 5aza 2′deoxycytidine and trichostatin A.
Milhem, M., Mahmud, N., Lavelle, D., Araki, H., DeSimone, J., Saunthararajah, Y., & Hoffman, R. (2004) · Blood · doi:10.1182/blood-2003-07-2431 · Cited by 195 · cited 4×
“…mice were sublethally irradiated with 300 cGy 4 hours prior to the infusion of PCs (2 × 10 5 ), and CD34 + cells reisolated after a week of culture under control conditions or cultures containing VPA in the presence or absence of cytokines were injected into NSG mice via the tail vein (17, 26, 27).”
InfluentialSelf-citationDe Felice, L., Tatarelli, C., Mascolo, M. G., Gregorj, C., Agostini, F., Fiorini, R., Gelmetti, V., Pascale, S., Padula, F., Petrucci, M. T., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3063 · Cited by 149
Araki, H., Yoshinaga, K., Boccuni, P., Zhao, Y., Hoffman, R., & Mahmud, N. (2007) · Blood · doi:10.1182/blood-2006-07-035287 · Cited by 98 · cited 4×
“…mice were sublethally irradiated with 300 cGy 4 hours prior to the infusion of PCs (2 × 10 5 ), and CD34 + cells reisolated after a week of culture under control conditions or cultures containing VPA in the presence or absence of cytokines were injected into NSG mice via the tail vein (17, 26, 27).”
InfluentialSelf-citation
Cited by
The nucleosome remodeling and deacetylase complex in development and disease
Basta, J., & Rauchman, M. (2015) · Translational Research · doi:10.1016/j.trsl.2014.05.003 · Cited by 191
Chagraoui, J., Girard, S., Spinella, J.-F., Simon, L., Bonneil, E., Mayotte, N., MacRae, T., Coulombe-Huntington, J., Bertomeu, T., Moison, C., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2020.12.002 · Cited by 93
Lysine-specific demethylase 1A restricts ex vivo propagation of human HSCs and is a target of UM171
Subramaniam, A., Žemaitis, K., Talkhoncheh, M. S., Yudovich, D., Bäckström, A., Debnath, S., Chen, J., Jain, M. V., Galeev, R., Gaetani, M., et al. (2020) · Blood · doi:10.1182/blood.2020005827 · Cited by 75
Effect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cells
Charaf, L., Mahon, F.-X., Lamrissi-Garcia, I., Moranvillier, I., Beliveau, F., Cardinaud, B., Dabernat, S., de Verneuil, H., Moreau-Gaudry, F., & Bedel, A. (2017) · Leukemia · doi:10.1038/leu.2016.154 · Cited by 16
Metadata
- Authors
- Chaurasia, P., Gajzer, D. C., Schaniel, C., D’Souza, S., & Hoffman, R.
- Venue
- Journal of Clinical Investigation
- Published
- 2014-04-24
- Volume
- 124
- Issue
- 6
- Pages
- 2378-2395
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2125371827
- Cited by
- 155
- References
- 8
- FWCI
- 10.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epigenetic reprogramming induces the expansion of cord blood stem cells. https://app.cochat.ai/papers/10.1172/jci70313
- The paper
- Chaurasia, P., Gajzer, D. C., Schaniel, C., D’Souza, S., & Hoffman, R. (2014). Epigenetic reprogramming induces the expansion of cord blood stem cells. Journal of Clinical Investigation. https://doi.org/10.1172/jci70313
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.